Nanotechnology and cancer

Annual Review of Medicine

Volumn 59, Issue , 2008, Pages 251-265

  Heath, James R ^a   Davis, Mark E ^a  

^a California Institute of Technology   (United States)

Author keywords

Cancer therapeutics; In vitro diagnostics; Microfluidics; Nanoparticles; Nanowires; Quantum dots

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ALBUMIN; ANTINEOPLASTIC AGENT; AP 5346; APREPITANT; CALAA 01; CAMPTOTHECIN; CARBON NANOTUBE; CT 2106; CYCLODEXTRIN; DAUNORUBICIN; DENILEUKIN DIFTITOX; DOXORUBICIN; GEMTUZUMAB OZOGAMICIN; GOLD; IBRITUMOMAB TIUXETAN; IT 101; LIPOSOME; MACROGOL; MBP 426; NANOPARTICLE; NK 012; NK 911; PACLITAXEL; PACLITAXEL POLIGLUMEX; PK 2; POLYAMIDOAMINE; POLYGLUTAMIC ACID; POLYLACTIC ACID; RAPAMYCIN; SGT 53; SP 1049C; TOSITUMOMAB I 131; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACCURACY; CANCER RESEARCH; CLINICAL TRIAL; COST; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; DNA MICROARRAY; DRUG CLEARANCE; DRUG HALF LIFE; HUMAN; IN VITRO STUDY; MEASUREMENT; MICROFLUIDIC ANALYSIS; NANOTECHNOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 39649092973     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.59.061506.185523     Document Type: Review

References (91)

1. Deleted in proof
2. Weinberg R. 2006. The Biology of Cancer. New York: Garland Sci.
3. Htoy S. 2001. New additions to the oncology arsenal: Assessing their place in therapy. Formulary 36:838-52
4. Lombardo LJ, Lee FY, Chen P, et al. 2004. Discovery of N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl) -2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. J. Med. Chem. 47:6658-61
5. Lamb J, Crawford ED, Peck D, et al. 2006. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313:1929-35
6. Hughes T, Branford S. 2003. Molecular monitoring of chronic myeloid leukemia. Semin. Hemat. 40:62-68
7. Price ND, Trent J, El-Naggar AK, et al. 2007. Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. PNAS 104:3414-19
8. Huang F, Reeves K, Han X, et al. 2007. Identification of candidate molecular markers predicting sensitivity in solid tumors to Dasatinib: rationale for patient selection. Cancer Res. 67:2226-38
9. Radich JP, Dai HY, Mao M, et al. 2006. Gene expression changes associated with progression and response in chronic myeloid leukemia. PNAS USA 103:2794-99
10. Paik S, Shak S, Tang G, et al. 2004. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 351:2817-26
11. Waldherr C, Mellinghoff IK, Tran C, et al. 2005. Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3′-deoxy-3′-F-18-fluorothymidine PET. J. Nucl. Med. 46:114-20
12. Alon U. 2007. An Introduction to Systems Biology: Design Principles of Biological Circuits. Boca Raton, FL: Chapman & Hall/CRC
13. Lin B, White JT, Lu W, et al. 2005. Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: a systems approach to disease. Cancer Res. 65:3081-91
14. Shiio Y, Suh KS, Lee H, et al. 2006. Quantitative proteomic analysis of Myc-induced apoptosis - a direct role for Myc induction of the mitochondrial chloride ion channel, mtCLIC/CLIC4. J. Biol. Chem. 281:2750-56
15. Hwang D, Rust AG, Ramsey JM, et al. 2005. A data integration metholodology for systems biology. Proc. Natl. Acad. Sci. USA 102:17296-301
16. Hood L, Heath JR, Phelps ME, et al. 2004. After the genome project: systems biology and new technologies enable predictive and preventive medicine. Science 306:640-43
17. Sawyers C. 2004. Targeted cancer therapy. Nature 432:294-97
18. Druker BJ. 2004. Molecularly targeted therapy: Have the floodgates opened? Oncologist 9:357-60
19. Wadleigh M, DeAngelo DJ, Griffin JD, et al. 2005. After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies. Blood 105:22-30
20. Carter TA, Wodicka LM, Shah NP, et al. 2005. Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases. Proc. Natl. Acad. Sci. USA 102:1011-16
21. Cristofanilli M, Budd GT, Ellis MJ, et al. 2004. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 351:781-91
22. Rosi NL, Mirkin CA. 2005. Nanostructures in biodiagnostics. Chem. Rev. 105:1547
23. Engvall E, Perlmann PO. 1972. Enzyme-linked immunosorbent assay, ELISA.3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J. Immunol. 109:129-35
24. Weller TH, Coons AH. 1954. Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro. Proc. Soc. Exp. Biol. 86:789-94
25. Zhang H, Cheng X, Richter M, et al. 2006. A sensitive and high-throughput assay to detect low-abundance proteins in serum. Nat. Med. 12:473-77
26. Schweitzer B, Wiltshire S, Lambert J, et al. 2000. Immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection. PNAS USA 97:10113-19
27. Fredriksson S, Dixon W, Ji H, et al. 2007. Multiplexed protein detection by proximity ligation for cancer biomarker validation. Nat. Methods 4:327-29
28. Park SJ, Taton TA, Mirkin CA. 2003. Array-based electrical detection of DNA with nanoparticle probes. Science 295:1503-6
29. Nam J-M, Thaxton CS, Mirkin CA. 2003. Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 301:1884-86
30. Waters LC, Jacobsen SC, Kroutchinina N, et al. 1998. Microchip device for cell lysis, multiplex PCR amplification, and electrophoretic sizing. Anal. Chem. 70:158-62
31. Xia YN, Whitesides GM. 1998. Soft lithography. Angew. Chem. Int. Ed. 37:550
32. Unger MA, Chou HP, Thorsen T, et al. 2000. Monolithic microfabricated valves and pumps by multilayer soft lithography. Science 288:113-16
33. Thorsen T, Maerkl SJ, Quake SR. 2002. Microfluidic large scale integration. Science 298:580-84
34. Zimmerman M, Delamarche E, Wolf M, et al. 2005. Modeling and optimization of high-sensitivity, low-volume microfluidic-based surface immunoassays. Biomed. Microdev. 7:99-110
35. Sheehan PE, Whitman LJ. 2005. Detection limits for nanoscale biosensors. Nano Lett. 5:803-7
36. Gascoyne P, Mahidol C, Ruchirawat M, et al. 2005. Microsample preparation by dielectrophoresis: isolation of malaria. Lab Chip 2:70-75
37. Crowley TA, Pizzoconi V. 2005. Isolation of plasma from whole blood using planar microfilters for lab-on-a-chip applications. Lab Chip 5:922-29
38. Petersson F, Nilsson A, Holm C, et al. 2005. Continuous separation of lipid particles from erythrocytes by means of laminar flow and acoustic standing wave forces. Lab Chip 5:20-22
39. Huang LR, Cox EC, Austin RH, et al. 2004. Continuous particle separation through deterministic lateral displacement. Science 304:987-90
40. Yang S, Undar A, Zahn JD. 2006. A microfluidic device for continuous, real time blood plasma separation. Lab Chip 6:871-80
41. Chen DS, Davis MM. 2005. Cellular immunotherapy: antigen recognition is just the beginning. Springer Semin. Immunopathol. 27:119-24
42. Lee PJ, Hung PJ, Rao VM, et al. 2006. Nanoliter scale microbioreactor array for quantitative cell biology. Biotech. Bioeng. 94:5-14
43. Toner M, Irimia D. 2005. Blood-on-a-chip. Annu. Rev. Biomed. Eng. 7:77-103
44. De Rosa SC, Herzenberg LA, Herzenberg LA, et al. 2001. 11 color, 13 parameter flow cytometry: identification of native T cells by phenotype, function and T cell receptor. Nat. Med. 7:245-48
45. Fu AY, Spence C, Scherer A, et al. 1999. A microfabricated fluorescence-activated cell sorter. Nat. Biotech. 17:1109-11
46. Deleted in proof
47. Cardoso AA, Watt SM, Batard P, et al. 1995. An improved panning technique for the selection of CD34+ human bone marrow hematopoietic cells with high recovery of early progenitors. Exp. Hemat. 23:407-12
48. Bailey RC, Kwong GA, Radu CG, et al. 2007. DNA-encoded antibody libraries: a unified platform for multiplexed cell sorting and detection of genes and proteins. J. Am. Chem. Soc. 129:1959-67
49. Karlsson R, Falt A. 1997. Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance. J. Immunol. Methods 200:121-33
50. Cui Y, Wei Q, Park H, et al. 2001. Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Science 293:1289-92
51. Kong J, Franklin NR, Zhou C, et al. 2000. Nanotube molecular wires as chemical sensors. Science 287:622-25
52. Heath JR. 2007. Label-free nanowire and nanotube biomolecular sensors for in vitro diagnosis of cancer and other diseases. In Nanobiotechnology II, ed. C Mirkin, C Niemeyer, pp. 213-28. Weinheim, Ger.: Wiley-VCH
53. Backmann N, Zahnd C, Huber F, et al. 2005. A label-free immunosensor array using single-chain antibody fragments. PNAS USA 102:14587-92
54. Lang HP, Hegner M, Gerber C. 2007. Cantilever array sensors for bioanalysis and diagnostics. In Nanobiotechnology II, ed. C Mirkin, C Niemeyer, Weinheim, Ger.: Wiley-VCH
55. Jung LS, Campbell CT, Chinowsky TM, et al. 1998. Quantitative interpretation of the response of surface plasmon resonance sensors to adsorbed films. Langmuir 14:5636-48
56. Bunimovich YL, Shin Y-S, Yeo W-S, et al. 2006. Quantitative real-time measurements of DNA hybridization with alkylated nonoxidized silicon nanowires in electrolyte solution. J. Am. Chem. Soc. 128:16323-31
57. Safsten P, Klakamp SL, Drake AW, et al. 2006. Screening antibody-antigen interactions in parallel using Biacore A100. Anal. Biochem. 353:181-90
58. Deleted in proof
59. Li M, Tang HX, Roukes ML. 2007. Ultra-sensitive NEMS-based cantilevers for sensing, scanned probe and very high-frequency applications. Nat. Nanotech. 2:114-20
60. Patolsky F, Zheng G, Hayden O, et al. 2004. Electrical detection of single viruses. PNAS USA 101:14017-22
61. McAlpine M, Ahmad H, Wang D, et al. 2007. Highly ordered nanowire arrays on plastic substrates for ultrasensitive flexible chemical sensors. Nat. Mat. 6:379
62. 3 nanowires and carbon nanotubes. J. Am. Chem. Soc. 127:12484-85
63. Zheng G, Patolsky F, Cui Y, et al. 2005. Multiplexed electrical detection of cancer markers with nanowire sensor arrays. Nat. Biotech. 23:1294-301
64. Israelachvili J. 1985. Intermolecular and Surface Forces. London: Academic
65. Javois LC, ed. 1999. Immunocytochemical Methods and Protocols. Totowa, NJ: Humana. 2nd ed.
66. Yezhelyev MV, Gao X, Xing Y, et al. 2006. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol. 7:657-67
67. Alivisatos AP, Gu W, Larabell C. 2005. Quantum dots as cellular probes. Annu. Rev. Biomed. Eng. 7:55-76
68. Liu X, Wang H, Herron J, et al. 2000. Photopatterning of antibodies on biosensors. Bioconjug. Chem. 11:755-61
69. Macbeath G, Schreiber SL. 2000. Printing proteins as microarrays for high-throughput function determination. Science 289:1760-63
70. Pal M, Moffa A, Sreekumar A, et al. 2006. Differential photophoprotein mapping in cancer cells using protein microarrays produced from 2-D liquid fractionation. Anal. Chem. 78:702-10
71. Thirumalapura NR, Morton RJ, Ramachandran A, et al. 2005. Lipopolysaccharide microarrays for the detection of antibodies. J. Immunol. Methods 298:73-81
72. Soen Y, Chen DS, Kraft DL, et al. 2003. Detection and characterization of cellular immune responses using peptide-MHC microarrays. PLoS Biol. 1:429-38
73. Bartlett DW, Davis ME. 2007. Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles. Bioconjug. Chem. 18:456-68
74. Song E, Zhu P, Lee SK, et al. 2005. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol. 23:709-17
75. Hong S, Leroueil PR, Majoros IJ, et al. 2007. The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem. Biol. 14:107-15
76. Montet X, Funovics M, Montet-Abou K, et al. 2006. Multivalent effects of RGD peptides obtained by nanoparticle display. J. Med. Chem. 49:6087-93
77. Carlson CB, Mowery P, Owen RM, et al. 2007. Selective tumor cell targeting using low-affinity, multivalent interactions. ACS Chem. Biol. 2:119-27
78. Zamboni WC. 2005. Liposomal, nanoparticle, and conjugated formulation of anticancer agents. Clin. Cancer Res. 11:8230-34
79. Sparreboom A, Scripture CD, Trieu V, et al. 2005. Comparative preclinical and clinical pharmacokinetics of a Cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol). Clin. Cancer Res. 11:4136-43
80. Sutton D, Nasongkla N, Blanco E, et al. 2007. Functionalized micellar systems for cancer targeted drug delivery. Pharmaceut. Res. 24:1029-46
81. Heidel JD, Yu Z, Liu JYI, et al. 2007. Administration in nonhuman primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc. Natl. Acad. Sci. USA 104:5715-21
82. Boddy AV, Plummer ER, Todd R, et al. 2005. A phase I and pharmacokinetic study of paclitaxel poliglumex (XYOTAX), investigating both 3-weekly and 2-weekly schedules. Clin. Cancer Res. 11:7834-40
83. Kraut EH, Fishman MN, LoRusso PM, et al. 2005. Final results of a phase I study of liposome encapsulated SN-38 (LE-SN38): safety, pharmacogenomics, pharmacokinetics, and tumor response. Poster presented at Annu. Meet. Am. Soc. Clin. Oncol., 41st, Orlando, FL
84. Daud A, Garrett C, Simon GR, et al. 2006. Phase I trial of CT-2106 (polyglutamated camptothecin) administered weekly in patients with advanced solid tumor malignancies. Poster presented at Annu. Meet. Am. Soc. Clin. Oncol., 42nd, Atlanta, GA
85. Yen Y, Synold T, Schluep T, et al. 2007. First-in-human phase I trial of a cyclodextrin-containing polymer-camptothecin nanoparticle in patients with various solid tumors. Presented at Annu. Meet. Am. Soc. Clin. Oncol., 43rd, Chicago, IL
86. Bross P, Beitz J, et al. 2001. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Clin. Cancer Res. 7:1490-96
87. Kawakami K, Nakajima O, Morishita R, et al. 2006. Targeted anticancer immunotoxins and cytotoxic agents with direct killing moieties. Sci. World J. 6:781-90
88. Allen TM. 2002. Ligand-targeted therapeutics in anticancer therapy. Nat. Rev. Cancer 2:750-63
89. Duncan R. 2006. Polymer conjugates as anticancer nanomedicines. Nat. Rev. Cancer 6:688-701
90. 2006. Safety study of MBP-426 (liposomal oxaliplatin suspension for injection) to treat advanced or metastatic solid tumors. ClinicalTrials.gov Identifier NCT003 55888. http://www.clinicaltrials.gov/ct/show/NCT00355888
91. 2007. Safety study of infusion of SGT-53 to treat solid tumors. ClinicalTrials.gov Identifier NCT0040613. http://www.clinicaltrials.gov/ct/ show/NCT00355888